Drug firms demand NPPA withdraw notices alleging overchargingPost published:August 30, 2017Post category:Industry NewsThe Indian Pharmaceutical Alliance has written to the pharma dept criticizing NPA for issuing demand notices to top drug makers over ‘suspected overcharging’ Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostSBI gears up for expected surge in affordable housing loan demand Next PostInfosys to start work on Kolkata centre: Mamata Banerjee You Might Also Like Creaform Opens a U.S. Automated Quality-Control Demonstration Center March 8, 2019 Power Partners releases PSAW65I Series of 65W interchangeable AC blade wall mount power supplies February 11, 2019 AIA’s The Vision Show December 23, 2017
Power Partners releases PSAW65I Series of 65W interchangeable AC blade wall mount power supplies February 11, 2019